Pediatric rheumatology

Characterization of juvenile idiopathic arthritis (JIA) subtypes, clinical features, treatment patterns, and early outcomes in Palestinian children: a retrospective cohort study

Pediatr Rheumatol Online JPublished Retrospective cohort study

Authors' conclusion

Systemic and PRF- JIA were linked to higher inflammatory activity and poorer short-term outcomes.

Study context

Population
Children diagnosed with JIA between January 2019 and August 2025, pediatric rheumatology centers in Hebron, Palestine
Participants
171 children
Exposure
Oligoarticular vs non-oligoarticular JIA
Outcome
Remission or relapse based on Wallace criteria
Follow-up
Six months
Methodological detailsmultivariable logistic regression
  • Multivariable logistic regression

Main finding

As reported in the abstract

Remission or relapse (Wallace criteria)

Achieved remission

53.8%

Relapsed

46.2%

Observational data: associations, not effects.

Further findings

Subtype distribution

Persistent oligoarticular JIA
38.0%
Polyarticular RF-negative (PRF-)
22.8%
Enthesitis-related arthritis (ERA)
14.6%

Clinical features

Knee arthritis (most frequent joint involvement)
63.7%
Systemic JIA: younger age at onset and higher inflammatory burden
Extra-articular manifestations (oral ulcers, rash, uveitis) differed across subtypes

Treatment use

NSAIDs
62.0%
MTX
79.5%
Biologics
22.2%

Factors associated with oligoarticular subtype (multivariable)

Younger age, knee involvement, lower ESR and six-month remission independently associated with oligoarticular subtype

Original publication

Characterization of JIA subtypes, clinical features, treatment patterns, and early outcomes in Palestinian children: a retrospective cohort study. Pediatr Rheumatol Online J. Published 27 February 2026. doi:10.1186/s12969-026-01194-8

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.